Australian start-ups and early-stage companies developing US/European regulatory and reimbursement strategies are encouraged to engage in AusBiotech’s newest BiotechTalk webcast, and to learn about the processes that are essential for commercial success in Australia and internationally.
The webcast, Regulatory and Reimbursement 101: the pathway to commercialisation, offers an opportunity to navigate product development through to international access strategy, including exploring how to take an idea from a prototype, through planning for manufacture, collaborating with “Big Medtech”, and taking your product to commericalisation.
Medical technology (device and diagnostics) reimbursements are an extremely important consideration for any medtech early-stage company or emerging SME. Fuelled by a value-driven healthcare environment, the reimbursement landscape can certainly present a wide spectrum of challenges.
Developed in collaboration with AusBiotech’s AusMedtech Advisory Group and AusMedtech Regulatory Affairs Advsiory Group, this platform offers a chance to meet esteemed and experienced speakers.
The seminar includes: Grant Bennett, Managing Director, PharmaLex Pty Ltd, and Chair, AusMedtech & Regulatory Affairs Advisory Groups; Rebecca Gaudin, Director of Regulatory Affairs, ANZ, Johnson and Johnson Innovation and Member, AusMedtech Regulatory Affairs Advisory Group; Sarah Griffin, Director, Medtechnique Consulting and Member, AusMedtech Advisory Group; Dr Greg Roger, Founder & Chief Executive Officer, Vestech Medical and Member, AusMedtech Advisory Group; and Ferando Gonzalo, VP Global Market Access, Cochlear, and AusBiotech Member.
The webcast will take place on Thursday 31 March 2022 via Zoom and is available free of charge to AusBiotech members and $75 for non-members. Register for Regulatory and Reimbursement 101: the pathway to commercialisation .
BiotechTalks is AusBiotech’s webcasting platform, and enables the Australian biotechnology industry to stay connected, present ideas, projects and updates, and exchange knowledge.
The conversation of regulating medtech will continue at Australia’s premier medical technology conference, , on 24-26 May, where an engaging line up of keynote speakers and knowledgeable panellists will share their expertise and insights to further advance the sector nationally and globally.
